Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Metastatic Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00924001
What this trial is testing

Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma

Who this might be right for
MelanomaMalignant MelanomaMelanoma, Experimental
National Cancer Institute (NCI) 1
Large-scale testing (Phase 3)UnknownNCT00039234
What this trial is testing

Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Stage IV Melanoma Metastatic to the Liver

Who this might be right for
Melanoma (Skin)Metastatic Cancer
Maxim Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT01124734
What this trial is testing

High Dose Interleukin-2 Followed by Intermittent Low Dose Temozolomide in Patients With Melanoma

Who this might be right for
Malignant Melanoma
Milton S. Hershey Medical Center 17
Very early researchStudy completedNCT04752267
What this trial is testing

18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Glioma+17 more
University of Southern California 10
Testing effectiveness (Phase 2)Study completedNCT01302496
What this trial is testing

Autologous TriMix-DC Therapeutic Vaccine in Combination With Ipilimumab in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Who this might be right for
Malignant Melanoma Stage IIIMalignant Melanoma Stage IV
Bart Neyns 39
Testing effectiveness (Phase 2)Looking for participantsNCT04771520
What this trial is testing

Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8+26 more
M.D. Anderson Cancer Center
Not applicableStudy completedNCT07436390
What this trial is testing

IFN-Gamma Expression as a Predictor of Response to Immune Checkpoint Inhibitors in First-Line Metastatic Melanoma

Who this might be right for
Metastatic MelanomaMalignant MelanomaSkin Cancer
Institute of Oncology Ljubljana 132
Not applicableActive Not RecruitingNCT07428252
What this trial is testing

Gastrointestinal Microbiome and Response to Immunotherapy in Metastatic Malignant Melanoma

Who this might be right for
Metastatic Malignant Melanoma
Institute of Oncology Ljubljana 150
Not applicableStudy completedNCT07256184
What this trial is testing

Prognostic and Treatment-Response Factors in Metastatic Melanoma: Multi-Center Analysis

Who this might be right for
Metastatic Malignant Melanoma
Ankara Etlik City Hospital 232
Not applicableStudy completedNCT02508909
What this trial is testing

Videoscopic Ilioinguinal Lymphadenectomy for Melanoma

Who this might be right for
MelanomaSecondary Malignant Neoplasm of Lymph Node
Istituto Oncologico Veneto IRCCS 23
Early research (Phase 1)Study completedNCT02716948
What this trial is testing

SRS and Nivolumab in Treating Patients With Newly Diagnosed Melanoma Metastases in the Brain or Spine

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic Malignant Neoplasm in the SpineStage IV Skin Melanoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 17
Large-scale testing (Phase 3)Study completedNCT00003027
What this trial is testing

Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Eastern Cooperative Oncology Group 482
Testing effectiveness (Phase 2)Study completedNCT05304546
What this trial is testing

Overcoming Primary Resistance to Immunotherapy in Metastatic Melanoma

Who this might be right for
Malignant MelanomaMetastatic MelanomaImmunotherapy+2 more
Dr. Ronnie Shapira 1
Early research (Phase 1)Study completedNCT01910181
What this trial is testing

Vemurafenib (Zelboraf) in Chinese Participants With BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 46
Testing effectiveness (Phase 2)WithdrawnNCT02535078
What this trial is testing

Phase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Advanced Cutaneous Melanoma

Who this might be right for
Malignant Melanoma
Immunocore Ltd
Testing effectiveness (Phase 2)UnknownNCT00116363
What this trial is testing

Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma

Who this might be right for
Malignant MelanomaNeoplasm Metastasis
Introgen Therapeutics 25
Testing effectiveness (Phase 2)Study completedNCT00039325
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma

Who this might be right for
Melanoma (Skin)
Jonsson Comprehensive Cancer Center 28
Not applicableEnded earlyNCT00991991
What this trial is testing

Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma

Who this might be right for
Melanoma (Skin)
Case Comprehensive Cancer Center 5
Testing effectiveness (Phase 2)Ended earlyNCT00707161
What this trial is testing

Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma

Who this might be right for
CancerMelanoma
University of Utah 6
Testing effectiveness (Phase 2)Study completedNCT00098553
What this trial is testing

Everolimus in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Alliance for Clinical Trials in Oncology 53
Next Page
50